News

The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye ...
Alcon Inc. has received its first Food and Drug Administration approval since its spinoff from Swiss medical giant Novartis ...
On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...
Researchers share that perfluorohexylactane eye drops offer rapid relief for dry eye disease, enhancing patient comfort ...
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...
Povicaine, launched in late 2024, has “become a staple in our practice,” Brandon D. Ayres, MD, said in this Healio Video Perspective from Kiawah Eye.
Alcon Inc. (NYSE:ALC) has announced that the U.S. Food and Drug Administration (FDA) has approved TRYPTYR (acoltremon ...
(Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment ...
AvKare did not specify what issues had been identified. The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned.
An eye drop manufacturer has announced a voluntary recall of certain dry eye drops after an audit from the U.S. Food and Drug Administration found "manufacturing cGMP deviations," and has advised ...
One lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) was recalled over fungal contamination after a consumer reported a foreign object floating in a vial.